- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03031431
Electricity-free Infant Warmer for Newborn Thermoregulation in Rwanda
January 9, 2020 updated by: Anne Hansen, Boston Children's Hospital
Hypothermia contributes to a significant portion of neonatal deaths.
Kangaroo mother care (KMC) is a safe and effective method of warming; however, it is not always feasible, and not possible in settings such as resuscitation or clinical instability.
Electric warmers are the standard of care in developed countries, but are extremely costly, complicated with risk of causing both hypo and hyperthermia with misuse, and often not feasible in settings without stable electricity.
Through a multi-institutional collaboration, the investigators have developed an electricity-free infant warmer.
After laboratory based prototype testing for safety and efficacy, the investigators aim to study the supervised use of the warmer under routine implementation conditions in a resource-limited setting.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Hypothermia contributes to a significant portion of neonatal deaths.
Kangaroo mother care (KMC) is a safe and effective method of warming; however, it is not always feasible, and not possible in settings such as resuscitation or clinical instability.
Electric warmers are the standard of care in developed countries, but are extremely costly, complicated with risk of causing both hypo and hyperthermia with misuse, and often not feasible in settings without stable electricity.
Through a multi-institutional collaboration, the investigators have developed an electricity-free infant warmer.
After laboratory based prototype testing for safety and efficacy, the investigators aim to study the supervised use of the warmer under routine implementation conditions in a resource-limited setting.
The primary aim of Phase 1 is to determine if the infant warmer is a safe, effective, usable and functional addition to KMC.
This is planned in a convenience sample of patients in two district hospitals, one in a relatively warm environment, and one in a colder setting using quantitative methods and observer audits of usability and functionality.
After determination of safety and effectiveness and making any necessary modifications to the warmer, Phase 2 aims to study the warmer in rural health centers and transport, as this is where we ultimately aim to use the electricity free devices due to the limited access to functioning and stable electricity in these settings.
The overall goal of the project is dissemination of the study results, and ultimately the infant warmer to the district and national level for key policy makers and stakeholders, as well as globally via publication.
Study Type
Interventional
Enrollment (Actual)
130
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rwinkwavu, Rwanda
- Dr Evrard Nahimana
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 3 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Any infant with the following criteria for whom caregiver is not available for Kangaroo Mother Care, or Kangaroo Mother Care is not adequate (less than ½ degree Celsius per hour rise in temperature).
- axillary temperature < 36 degrees C and ≥35 degrees C 1a) If an electric warmer is available and the infant's temperature is < 35 degrees C, then the infant would start by being warmed on the electric warmer until the infant's temperature reaches 36 degrees C, then can start non-electric infant warmer use
- Infants at-risk for hypothermia (criteria: estimated post-menstrual age of < 35 weeks or current body weight of < 2.5 kg)
Exclusion Criteria:
- Any infant whose family is unwilling to consent to study.
- Mothers who are critically ill at the time of infant eligibility or deemed not medically stable by nursing staff to be approached for consent.
- Any infant with a contraindication to Kangaroo Mother Care (medical instability) and electrical heating source available.
- Any infant with initial temperature < 35 degrees C and electrical heating source available.
- Infants within the first hour of admission to neonatal unit or first hour of life in maternity.
- Infants requiring phototherapy
- Infants with significant skin condition
- Infants with Hypoxic Ischemic Encephalopathy (HIE)
Stopping Criteria:
If an electric heating source is available, the infant will be taken off the study and warmed with an appropriate source of electric heat if the infant:
- Is hypothermic and temperature decreases on any measurement
- Is hypothermic and temperature does not begin to rise within 30 minutes
- Is hypothermic and not heating at a rate of > ½ degree C per hour until temperature is >36.5 degrees C
- Has a temperature that falls below 36 degrees C despite maximum exposure to the heat source
- Is ever considered to be too severely ill by the medical team to be safely cared for in the non-electric infant warmer.
- The warmer will be removed once its temperature drops below 36 degrees, and/or the phase change material begins to harden.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Non-Electric Infant Warmer
In line with current recommended practice, mothers will be encouraged to provide Kangaroo Mother Care (KMC) whenever possible.
If an infant's temp is not rising by ½ degree C per hour with KMC alone, the infant warmer will be offered as an addition by the study team.
If the mother is not available for KMC at any time, the infant will be warmed exclusively with the warmer.
Bundling in clothes will only be used in addition to the warmer per carer preference.
Temp measurement of the infant, warmer, and ambient air will be measured every 15 mins for the first hr, then hrly and as needed for the remainder of use or until warmer endpoint is reached (warmer temp below 36 degrees or phase-change material hardens [soft, semisoft, or hardened]).
|
Electric warmers are the standard of care in developed countries, but are extremely costly, complicated with risk of causing both hypo and hyperthermia with misuse, and often not feasible in settings without stable electricity.
Through a multi-institutional collaboration, the investigators have developed an electricity-free infant warmer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Temperature/Effectiveness
Time Frame: Up to 6 months
|
The infant warmer will be evaluated on the number of time is able to successfully achieve and maintain a normal body temperature for patients who are hypothermic and those patients at risk of hypothermia because of a < 2.5 kg birth weight or < 35 week gestational age.
|
Up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Usability
Time Frame: Up to 6 months
|
The investigators will use observation to evaluate the usability of the warmer by assessing whether or not the infant warmer was used in a way that deviated from its recommended use.
|
Up to 6 months
|
Functionality
Time Frame: Up to 6 months
|
The functionality will be assessed by whether or not there appeared to be wear and tear on the infant warmer based on repeated use.
|
Up to 6 months
|
Qualitative Survey
Time Frame: Up to 1 year
|
The same as primary outcome and secondary outcome as described above with the setting being clinic and transport based rather than in a hospital, and with the addition of qualitative questions for mother and nurse regarding infant warmer use.
|
Up to 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Anne Hansen, MD, Boston Children's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2016
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
July 1, 2019
Study Registration Dates
First Submitted
December 13, 2016
First Submitted That Met QC Criteria
January 23, 2017
First Posted (Estimate)
January 25, 2017
Study Record Updates
Last Update Posted (Actual)
January 13, 2020
Last Update Submitted That Met QC Criteria
January 9, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-P00016205
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypothermia Neonatal
-
William Marsh Rice UniversityKamuzu University of Health SciencesRecruiting
-
William Marsh Rice UniversityKamuzu University of Health SciencesRecruiting
-
William Marsh Rice UniversityUniversity of Lagos, NigeriaRecruiting
-
William Marsh Rice UniversityIfakara Health Institute; Muhimbili University of Health and Allied Sciences; Ministry of Health, Community Development, Gender, Elderly, and Children (MOHCDGEC)Recruiting
-
Boston Children's HospitalHarvard Medical School (HMS and HSDM); Ministry of Health, Rwanda; Partners in... and other collaboratorsUnknownHypothermia NeonatalRwanda
-
Aliona Vilinsky-RedmondCompletedNeonatal HypothermiaIreland
-
University Hospital PadovaCompletedNeonatal HypothermiaItaly
-
Thayyil, SudhinWayne State UniversityActive, not recruitingNeonatal Encephalopathy | Magnetic Resonance Spectroscopy | Hypothermia NeonatalUnited Kingdom, United States, Italy
-
Princess Anna Mazowiecka Hospital, Warsaw, PolandRecruitingPerinatal Asphyxia | Hypothermia Neonatal | Haemodynamic InstabilityPoland
-
University of Texas Southwestern Medical CenterParkland Health and Hospital SystemCompletedCesarean Section | Hypothermia | Neonatal OutcomeUnited States
Clinical Trials on Non-Electric Infant Warmer
-
Boston Children's HospitalHarvard Medical School (HMS and HSDM); Ministry of Health, Rwanda; Partners in... and other collaboratorsUnknownHypothermia NeonatalRwanda
-
Danone Asia Pacific Holdings Pte, Ltd.Completed
-
Xijing HospitalAir Force Military Medical University, ChinaCompletedStroke | Brain InjuriesChina
-
Wyss Center for Bio and NeuroengineeringEcole Polytechnique Fédérale de LausanneCompleted
-
Alabama Physical Therapy & AcupunctureUniversidad Rey Juan CarlosRecruitingTension-Type HeadacheUnited States
-
The University of The West IndiesInternational Atomic Energy AgencyUnknown
-
Xijing HospitalCompletedTherapeutic (Nonsurgical) and Rehabilitative Anesthesiology Devices Associated With Adverse IncidentsChina
-
Yonsei UniversityCompletedMyofascial Pain Syndrome of the Upper TrapeziusKorea, Republic of
-
Boehringer IngelheimCompleted
-
Beijing YouAn HospitalUnknownHepatocellular CarcinomaChina